Robert Noveck
Clinical Pharmacology · Durham, NCNPI 1336330356
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$2,790,653in research payments, 2019–2025
Across 399 payments — averaging $6994.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1.1M
- Boehringer Ingelheim$518K
- Janssen Research & Development, LLC$277K
- Eli Lilly$245K
- Novavax Inc$125K
- Johnson & Johnson$116K
- plus $414K from 12 others
How this compares
Too few clinical pharmacology providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.